LG Chem announced that it participated in the Blue Tree Campaign organized by the Korean Diabetes Association in recognition of World Diabetes Day on November 14. The company held an awareness event for its employees on November 15.
The Blue Tree Campaign, themed "Blue Light, Better Tomorrow," aims to promote the understanding and awareness of diabetes as a condition that should be managed by the community rather than individuals alone.
LG Chem set up a campaign space at its LG Science Park headquarters in Magok, Seoul. Employees received the official mascot doll 'Dangdang-i' from the Korean Diabetes Association and keychains featuring the campaign slogan, symbolizing the significance of blue light in fostering proper understanding and interest in diabetes.
A company representative stated, "This event emphasizes the importance of regular check-ups for early detection of diabetes and blood sugar management."
According to data from the market research firm Ubist, the prescription amount for diabetes medications in the third quarter of this year reached 480 billion won, a 9.8% increase from the previous quarter. The market anticipates that the annual prescription amount will exceed 2 trillion won next year.
The diabetes medication market is led by new drugs and treatments such as LG Chem's 'Gemimet', Boehringer Ingelheim's 'Jardiance', and Eli Lilly's 'Trulicity'.
The Blue Tree Campaign, themed "Blue Light, Better Tomorrow," aims to promote the understanding and awareness of diabetes as a condition that should be managed by the community rather than individuals alone.
LG Chem set up a campaign space at its LG Science Park headquarters in Magok, Seoul. Employees received the official mascot doll 'Dangdang-i' from the Korean Diabetes Association and keychains featuring the campaign slogan, symbolizing the significance of blue light in fostering proper understanding and interest in diabetes.
A company representative stated, "This event emphasizes the importance of regular check-ups for early detection of diabetes and blood sugar management."
According to data from the market research firm Ubist, the prescription amount for diabetes medications in the third quarter of this year reached 480 billion won, a 9.8% increase from the previous quarter. The market anticipates that the annual prescription amount will exceed 2 trillion won next year.
The diabetes medication market is led by new drugs and treatments such as LG Chem's 'Gemimet', Boehringer Ingelheim's 'Jardiance', and Eli Lilly's 'Trulicity'.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.